Recent News
Recent news and publications from the Cancer Cluster
Lukong lab - Cell Signal paper
BRK confers tamoxifen-resistance in breast cancer via regulation of tyrosine phosphorylation of CDK1
Vizeacoumar lab - Cell Reports paper with Freywald lab
Integration of cancer-related genetic landscape of Eph receptors and ephrins with proteomics identifies a crosstalk between EPHB6 and EGFR
Vizeacoumar lab - Clin Canc Res paper with Freywald lab
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy
Lukong lab - Heliyon paper
Seeking a better understanding of the non-receptor tyrosine kinase, SRMS
Vizeacoumar lab - Methods Mol Biol. paper
A CRISPR Platform for Targeted In Vivo Screens
Wu & Vizeacoumar labs - Front Oncol. paper
Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy
Anderson & Vizeacoumar labs - Sci Rep paper
Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel
Congratulations Dean Chamberlain was awarded a grant from the Saskatchewan Health Research Foundation
Development of 3D tissue engineered tumour microtissue models for precision medicine
Xiang lab - Int J Mol Sci paper
The Critical Role of AMPKα1 in Regulating Autophagy and Mitochondrial Respiration in IL-15-Stimulated mTORC1Weak Signal-Induced T Cell Memory: An Interplay between Yin (AMPKα1) and...
Lukong lab - J Cancer Res Clin Oncol paper
Triple negative breast cancer: approved treatment options and their mechanisms of action
Vizeacoumar lab - Cells paper
A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers
Anderson lab - PLoS One paper
Reduced CREB3L1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis